Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapy
对接受化疗免疫疗法治疗的转移性恶性黑色素瘤患者进行可溶性IL-2受体水平的随访
期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1111/j.1365-2249.1994.tb06516.x
Soubrane, C; Mouawad, R; Ichen, M; Suissa, J; Borel, C; Vuillemin, E; Benhammouda, A; Bizzari, J P; Weil, M; Khayat, D